1,015 Shares in Axon Enterprise, Inc $AXON Acquired by Perennial Investment Advisors LLC

Perennial Investment Advisors LLC acquired a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,015 shares of the biotechnology company’s stock, valued at approximately $569,000.

A number of other large investors have also recently bought and sold shares of the company. Ausdal Financial Partners Inc. purchased a new stake in shares of Axon Enterprise during the 2nd quarter worth about $505,000. Bamco Inc. NY acquired a new stake in Axon Enterprise in the second quarter valued at approximately $86,118,000. Bank of America Corp DE purchased a new stake in shares of Axon Enterprise in the second quarter valued at approximately $286,684,000. Odyssean LLC raised its stake in shares of Axon Enterprise by 78.5% during the 2nd quarter. Odyssean LLC now owns 3,681 shares of the biotechnology company’s stock worth $2,064,000 after buying an additional 1,619 shares during the period. Finally, Man Group plc acquired a new position in shares of Axon Enterprise during the 2nd quarter worth approximately $5,805,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

AXON has been the subject of several research analyst reports. TD Cowen restated a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, July 22nd. Morgan Stanley increased their price target on Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. JPMorgan Chase & Co. boosted their price target on shares of Axon Enterprise from $750.00 to $755.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. UBS Group increased their price target on Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a report on Thursday, August 6th. Finally, Needham & Company LLC reaffirmed a “buy” rating on shares of Axon Enterprise in a research report on Thursday, August 6th. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus price target of $730.92.

Insider Buying and Selling

In related news, insider Elizabeth Reid Coughlin sold 1,554 shares of the company’s stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $485.00, for a total value of $753,690.00. Following the completion of the sale, the insider owned 34,024 shares in the company, valued at $16,501,640. This represents a 4.37% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Patrick W. Smith sold 9,930 shares of the stock in a transaction on Friday, August 7th. The stock was sold at an average price of $548.77, for a total transaction of $5,449,286.10. Following the sale, the chief executive officer owned 3,031,067 shares of the company’s stock, valued at approximately $1,663,358,637.59. This represents a 0.33% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 76,594 shares of company stock valued at $41,236,386 in the last 90 days. Company insiders own 4.20% of the company’s stock.

Axon Enterprise Price Performance

Shares of AXON opened at $607.48 on Thursday. The firm has a market capitalization of $49.35 billion, a price-to-earnings ratio of 252.07, a PEG ratio of 9.95 and a beta of 1.39. The firm’s fifty day simple moving average is $553.45 and its 200-day simple moving average is $480.77. Axon Enterprise, Inc has a twelve month low of $339.01 and a twelve month high of $794.29. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm had revenue of $904.39 million during the quarter, compared to the consensus estimate of $876.42 million. During the same quarter in the previous year, the firm posted $2.12 earnings per share. The company’s revenue was up 35.3% compared to the same quarter last year. Equities analysts forecast that Axon Enterprise, Inc will post 2.04 EPS for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.